Article
Data reveal shift in prostate Ca treatment choices
Las Vegas--Brachytherapy is a growing treatment choice for menwith low-risk prostate cancer, although it is still selected by less than22% of men with the disease, according to San Francisco researchers. Theuse of androgen ablation has also increased, the researchers found in ananalysis of data from the CaPSURE database.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Related Videos
Expert discusses setting realistic expectations for Rezum for BPH
Considering Therapy De-Intensification: Balancing Adverse Effects and PSA Response
Nicolette G. Payne, MD, discusses risk factors for burnout among pediatric urologists
Sacral neuromodulation device empowers patients with greater UUI control
Howard Goldman, MD, on his experience with the Glean Urodynamics System
Remaining Unmet Needs in NMIBC: Closing Thoughts From Expert Panel
Urology Crossroads: Looking Ahead in the Era of Immunotherapy for NMIBC
Study: Women with SCI are more likely to use indwelling catheters
Discover the Art and Science Behind Nerve Sparing Prostate Surgery
Ziho Lee, MD, previews 2025 Northwestern GU robotic reconstruction course
Related Content
